PDF
ePub
Citation
Print
초록
Purpose
The purpose of this study was to identify the experiences of patients with ovarian cancer undergoing chemotherapy.
Methods
A phenomenological method was used in this study. Data were collected by individual in-depth interviews with six participants with ovarian cancer undergoing chemotherapy during 2016. Colaizzi's phenomenology has been adopted as a research method in this qualitative study.
Results
Seven theme clusters were derived from the data as follows: ‘Recognizing cancer diagnosis and treatment as braking in life,’ ‘Effect on being a housewife as a cancer patient,’ ‘Ambivalence about treatment,’ ‘Fear with physical side effects,’ ‘Losing sexuality as a woman,’ ‘Affected by other ovarian cancer patients,’ ‘Practice hope after treatment.’
REFERENCES
1. Ministry of Health and Welfare(KR); National Cancer Center (KR). Cancer facts & figures 2016 in the Republic of Korea. Sejong: Ministry of Health and Welfare;2016.
2. Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016; 48:436–50.
3. Kim SC. Recent advances in ovarian cancer treatment. J Korean Med Assoc. 2016; 59:164–6.
4. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016; 66:7–30.
5. Chang SJ. Surgical management of ovarian cancer. J Korean Med As-soc. 2016; 59:167–74.
6. Lim MC, Park SY. Chemotherapy for ovarian cancer. J Korean Med As-soc. 2016; 59:175–9.
7. Meraner V, Gamper EM, Grahmann A, Giesinger JM, Wiesbauer P, Sz-tankay M, et al. Monitoring physical and psychosocial symptom trajec-tories in ovarian cancer patients receiving chemotherapy. BMC Cancer. 2012; 12:77.
8. Penar-Zadarko B, Binkowska-Bury M, Wolan M, Gawelko J, Urbanski K. Longitudinal assessment of quality of life in ovarian cancer patients. Eur J Oncol Nurs. 2013; 17:381–5.
9. Ezendam NP, Pijlman B, Bhugwandass C, Pruijt JF, Mols F, Vos MC, et al. Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: results from the population-based PROFILES registry. Gynecol Oncol. 2014; 135:510–7.
10. Hopkins TG, Stavraka C, Gabra H, Fallowfield L, Hood C, Blagden S. Sexual activity and functioning in ovarian cancer survivors: an inter-net-based evaluation. Climacteric. 2015; 18:94–8.
11. Hwang KH, Cho OH, Yoo YS. Symptom clusters of ovarian cancer patients undergoing chemotherapy, and their emotional status and quality of life. Eur J Oncol Nurs. 2016; 21:215–22.
12. Kim K, Lee M, Kwak Y, Kim JS. Factors affecting the fatigue of hospitalized women cancer patients receiving chemotherapy. Asian Oncol Nurs. 2014; 14:182–90.
13. Lee ES, Park JS. The comparison of health promotion behavior, post traumatic growth and quality of life according to stages of survivorship in patients with female genital neoplasm. Korean J Adult Nurs. 2013; 25:312–21.
14. Nho JH, Kim SR, Kang GS, Kwon YS. Relationships among malnutri-tion, depression and quality of life in patients with gynecologic cancer receiving chemotherapy. Korean J Women Health Nurs. 2014; 20:117–25.
15. Yu SY, Nho JH. Influence of sleep disturbance and depression on quality of life in ovarian cancer patients during chemotherapy. Asian Oncol Nurs. 2015; 15:203–10.
16. Espinosa PP, Espinosa MJ. Experiences to chemotherapy among women with breast cancer. Int J Bio Sci Bio Technol. 2016; 8:159–66.
17. Park JA. The experienced of chemotherapy before stem cell transplan-tation in patients with hematologic malignancy. Qual Res. 2015; 16:34–47.
18. Colaizzi PE. Psychological research as the phenomenologist views it. New York, NY: Oxford University Press;1978.
19. Lincoln YS, Guba EG. Naturalistic inquiry. Newbury Park, CA: SAGE Publications. 1985.
21. DellaRipa J, Conlon A, Lyon DE, Ameringer SA, Lynch Kelly D, Men-zies V. Perceptions of distress in women with ovarian cancer. Oncol Nurs Forum. 2015; 42:292–300.
22. Witham G, Haigh C, Foy S. The challenges of health professionals in meeting the needs of vulnerable patients undergoing chemotherapy: a focus group study. J Clin Nurs. 2014; 23:2844–53.
23. Spichiger E, Rieder E, Müller-Fröhlich C, Kesselring A. Fatigue in patients undergoing chemotherapy, their self-care and the role of health professionals: a qualitative study. Eur J Oncol Nurs. 2012; 16:165–71.
24. Heo SM, Heo N. Experiences of self-management support among breast cancer survivors. Korean J Adult Nurs. 2016; 28:470–81.
25. Moradian S, Howell D. Prevention and management of chemotherapy-induced nausea and vomiting. Int J Palliat Nurs. 2015; 21:216–24.
26. Farrell C, Brearley SG, Pilling M, Molassiotis A. The impact of chemotherapy-related nausea on patients’ nutritional status, psychological distress and quality of life. Support Care Cancer. 2013; 21:59–66.
27. Olver I, Molassiotis A, Aapro M, Herrstedt J, Grunberg S, Morrow G. Antiemetic research: future directions. Support Care Cancer. 2011; 19.
28. List⊘l W, H⊘berg-Vetti H, Eide GE, Bjorvatn C. Anxiety and depression symptoms among women attending group-based patient education courses for hereditary breast and ovarian cancer. Hered Cancer Clin Pract. 2017; 15:2.
29. Gaston-Johansson F, Haisfield-Wolfe ME, Reddick B, Goldstein N, La-wal TA. The relationships among coping strategies, religious coping, and spirituality in African American women with breast cancer receiving chemotherapy. Oncol Nurs Forum. 2013; 40:120–31.
Table 1.
Theme Clusters and Themes of Experience of Chemotherapy in Ovary Cancer Patients
XML Download